Two board appointments at EyeGate Pharma
This article was originally published in Scrip
EyeGate Pharma (US) has appointed Paul Chaney chairman of the board and Dr Morton Goldberg as director. Mr Chaney is a consultant at Eyetech, which recently spun out of (OSI) Eyetech, OSI's eye care subsidiary. He was previously executive vice-president of OSI Pharmaceuticals and president of (OSI) Eyetech. Dr Goldberg is a Joseph E Green professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine.